Inducing apoptosis and completely eliminating ErbB2‐expressing MDA‐MB453 SKBR3 breast carcinoma cell lines (in vitro) and inhibiting the in vivo growth of ErbB2‐expressing tumour cells by NK‐92 scFv(FRP5)‐zeta cells. The gene discussed is ERBB2; the disease is neoplasm.